Streetbeat News

Stock Prices

FGEN

REGN

FibroGen Inc (NASDAQ:FGEN) shares surged in after-hours trading following the FDA's clearance of its Investigational New Drug (IND) for FG-3165 and a new clinical trial supply agreement with Regeneron Pharmaceuticals (NASDAQ:REGN). FG-3165 is a galectin-9 targeted monoclonal antibody for treating solid tumors. Phase 1 trials are set to begin in the second half of 2024.

Portfolio Pulse from Adam Eckert

June 03, 2024 | 8:48 pm

SHIP

Sphinx Investment has released a statement regarding its investment in Seanergy Maritime, addressing ongoing litigation and shareholder proposals. Sphinx criticizes Seanergy's recent media statements and press release, suggesting that the company is attempting to mislead shareholders about the actions of its CEO and Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:47 pm

TER

Whales have shown a bullish stance on Teradyne (NASDAQ:TER) with significant options activity. Analysts have set an average price target of $158.4, with recent upgrades from Goldman Sachs. The stock is currently trading at $141.02 with a slight increase of 0.06%.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:45 pm

NET

Deep-pocketed investors have shown a bearish sentiment towards Cloudflare (NYSE:NET), with significant options activity detected. The majority of the trades are puts, indicating a bearish outlook. Analysts have mixed ratings, with price targets ranging from $80 to $120.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:45 pm

SPY

USO

President Biden is set to sign an executive order on border security, and G7 leaders have endorsed a Gaza deal announced by Biden. Additionally, the NYSE has resolved a technical glitch.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:42 pm

LVRO

Lavoro (NASDAQ:LVRO) reported a significant quarterly loss of $(0.50) per share, missing the analyst consensus estimate of $0.02 by a wide margin. The company's sales also fell short of expectations, coming in at $514.20 million compared to the estimated $619.07 million.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:35 pm

HQY

HealthEquity, Inc. (NASDAQ:HQY) shares are climbing after the company reported better-than-expected Q1 results and strong forward guidance. The company reported earnings of 80 cents per share, beating the analyst consensus estimate of 66 cents, and quarterly sales of $287.6 million, surpassing the estimate of $278.11 million. HealthEquity also raised its full-year guidance.

Portfolio Pulse from Erica Kollmann

June 03, 2024 | 8:32 pm

BARK

BGFV

EJH

GES

NAAS

SPGC

UCAR

VOXX

VRM

The article highlights the performance of various consumer discretionary stocks during Monday's after-market session. Notable gainers include Sacks Parente Golf, U Power, Visionary Holdings, Vroom, E-Home Household Service, and VOXX International. On the losing side, BARK, Smart Share Global, Boqii Holding, Guess, Big 5 Sporting Goods, and Naas Technology saw declines.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:31 pm

BGXX

BIMI

CADL

CCM

CPHI

FGEN

GRTS

NNVC

NOTV

NVOS

RAPT

SRRK

The article highlights the performance of 12 health care stocks during Monday's after-market session. Notable gainers include FibroGen, Candel Therapeutics, and RAPT Therapeutics, while significant losers include Bright Green, Nanoviricides, and Concord Medical Services.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:31 pm

AGFY

CAPT

CBAT

CREG

HYZN

JCSE

JYD

NMHI

PMEC

SIDU

VCIG

VLRS

The article highlights the performance of 12 industrial stocks during Monday's after-market session. Captivision (CAPT), VCI Global (VCIG), Controladora Vuela (VLRS), Sidus Space (SIDU), Jayud Global Logistics (JYD), and CBAK Energy Tech (CBAT) saw gains, while Primech Holdings (PMEC), Hyzon Motors (HYZN), JE Cleantech Holdings (JCSE), Smart Powerr (CREG), Nature's Miracle Holding (NMHI), and Agrify (AGFY) experienced losses.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:31 pm